Photo: Zsazsalini · CC BY-SA 4.0
15 checked claims
across 1 source
bronze frame — under 20 claims checked
What Angela Rasmussen talks about
A sample that mirrors their checked record and spreads across their subjects — not their worst claimsEvery row is reachable by scrolling its column · search matches claim text, verdicts, people, topics and sources · hover a row to trace its chain, click one to pin its detail
Claims by source
No claims match the selected verdicts.
Did COVID Actually Come From a LAB?
15 attributed claims Published August 2026
-
The analysis indicated that SARS-CoV-2 entered humans through two separate spillover events about two weeks apart.
Pekar et al.'s phylodynamic analysis concluded that the two early viral lineages, A and B, resulted from at least two separate cross-species transmissions, with lineage A introduced within weeks of lineage B. The evidence supports the claim as stated that the analysis indicated two events roughly two weeks apart.
-
The Huanan market origin can be described as occurring from live animals exactly as SARS-CoV-1 did in Guangzhou markets.
Evidence from the 2003 SARS outbreak linked infection risk and SARS-like viruses to live-animal markets in southern China, including Guangzhou and Shenzhen. However, contemporary CDC research explicitly stated that the reservoir remained unknown, so the phrase “exactly like” creates a stronger and more specific impression than the evidence supports.
Sources used for this check
-
Multiple U.S. agencies appear to believe that COVID-19 originated at the Wuhan Institute of Virology.
The U.S. intelligence community was divided, but the public ODNI assessment did not say that multiple agencies specifically concluded the virus originated at WIV. It said one agency favored a laboratory incident probably involving WIV, while DOE and FBI favored a laboratory-associated incident for different reasons.
-
The Department of Energy assessed that COVID-19 came specifically from the Wuhan CDC.
Publicly released U.S. assessments state only that DOE judged a laboratory-associated incident most likely; they do not publicly identify the Wuhan CDC as the source. Because DOE's underlying intelligence remains classified, the more specific attribution cannot be confirmed or refuted from available evidence.
-
A progenitor virus has not been found either in nature or in a laboratory freezer.
No immediate or close progenitor of SARS-CoV-2 has been identified in sampled bats or publicly documented as being held in a Wuhan laboratory. The ODNI report also says it found no known WIV virus that could plausibly be a progenitor.
-
Very closely related SARS-CoV-2-like viruses have been found in bats in Laos.
Researchers identified SARS-CoV-2-related sarbecoviruses in cave bats in northern Laos. These viruses are among the closest known relatives of SARS-CoV-2, although they are not the progenitor virus itself.
-
There is a cluster of SARS-CoV-2-positive market samples in the area where animals were sold.
Analyses of Huanan market sampling found a positivity hotspot near wildlife stalls and detected SARS-CoV-2 together with genetic material from susceptible wildlife. This supports the stated spatial association, but does not by itself prove that an infected animal transmitted the virus to humans.
-
The P3CO framework effectively defined the relevant research as enhancing a virus’s transmissibility and/or pathogenicity or virulence in humans.
The speaker captures the core biological criterion, but presents it as if any experiment that makes a virus more transmissible or severe in humans automatically falls under P3CO. The official framework applies the criterion within a narrower regulatory framework involving reasonably anticipated enhanced potential pandemic pathogens.
Sources used for this check
-
Under the P3CO regulatory definition in effect at the time, the Wuhan-related experiments did not fall into the category of gain-of-function research subject to that framework.
Under the U.S. government’s operative P3CO classification, NIH and Fauci stated that the Wuhan subaward research did not meet the regulatory definition requiring that designation. The experiments can still be described as gain-of-function under broader scientific usage, but that is not the narrower claim made here.
-
The purpose of this type of work was to examine naturally circulating coronaviruses and assess which ones posed pandemic threats.
The NIH-funded project was designed to study bat coronaviruses, evaluate their zoonotic or pandemic potential, and support preparedness against future coronavirus outbreaks. The cited 2015 study likewise described examining the disease potential of a circulating bat coronavirus.
-
The experiments included inserting one coronavirus’s spike protein into another viral backbone and testing whether the resulting virus could infect human cells or replicate in mice expressing human receptors.
The published research describes creating a chimeric virus with a bat-coronavirus spike in a SARS-CoV backbone, testing it in primary human airway cells, and evaluating related chimeric viruses in humanized mice. The exact experimental systems varied across studies, but the factual description is supported.
-
Greater virus growth in an experiment does not necessarily mean greater transmissibility.
Replication or yield in a particular cell-culture system is not, by itself, a direct measure of transmission between infected hosts. Cell-culture experiments do not capture the tissue, host, behavioral and epidemiological factors that determine transmissibility.
-
The purpose of the research was to assess pandemic risk rather than to make viruses deadlier merely for its own sake.
Federal policy documents show that some enhanced-pathogen research was evaluated in terms of pandemic risk and potential benefits, but the transcript does not identify the specific researchers or experiments, and research motives cannot be established from this statement alone.
-
The MMR vaccine is 97% effective.
CDC reports that two doses of measles vaccine are about 97% effective against measles, but the figure does not describe uniform protection against all three diseases in MMR or apply regardless of dose. The unqualified wording therefore creates a misleading impression about the vaccine's overall effectiveness.
Sources used for this check
-
Monovalent vaccines are unavailable, so measles, mumps, and rubella cannot be obtained individually.
CDC says single-antigen measles vaccine is not available in the United States, supporting the claim in that jurisdiction. However, WHO documents monovalent measles and rubella vaccines as available options, so the unqualified statement gives a misleading global impression.
Sources used for this check